Source: Annual Congress 2010 - Immune modulation of airways diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kelly, C. Gwozd, W. Ooyelusi, P. Kubes (Calgary, Canada). The role of pulmonary structural cells in pulmonary fibrosis in a model of hypersensitivity pneumonitis. Eur Respir J 2010; 36: Suppl. 54, 1922

Member's Comments

No comment yet.

Related content which might interest you: Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019 Year: 2019 Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: International Congress 2019 – Lungs in the fog Year: 2019 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Pulmonary hypertension in hypersensitivity pneumonitis. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 The challenge of acute exacerbation of pulmonary fibrosis Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis Source: Eur Respir J 2014; 44: 415-424 Year: 2014 Emergencies in interstitial and immunological lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177 Year: 2006 The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 The effect of pulmonary macrophage transplantation in the pulmonary fibrosis of mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 The immunomodulatory effect of protein S in pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis. Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019